Genomic characterization of DICER1-associated neoplasms uncovers molecular classes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 03 2023
Historique:
received: 06 10 2022
accepted: 28 02 2023
medline: 28 3 2023
entrez: 25 3 2023
pubmed: 26 3 2023
Statut: epublish

Résumé

DICER1 syndrome is a tumor predisposition syndrome that is associated with up to 30 different neoplastic lesions, usually affecting children and adolescents. Here we identify a group of mesenchymal tumors which is highly associated with DICER1 syndrome, and molecularly distinct from other DICER1-associated tumors. This group of DICER1-associated mesenchymal tumors encompasses multiple well-established clinicopathological tumor entities and can be further divided into three clinically meaningful classes designated "low-grade mesenchymal tumor with DICER1 alteration" (LGMT DICER1), "sarcoma with DICER1 alteration" (SARC DICER1), and primary intracranial sarcoma with DICER1 alteration (PIS DICER1). Our study not only provides a combined approach to classify DICER1-associated neoplasms for improved clinical management but also suggests a role for global hypomethylation and other recurrent molecular events in sarcomatous differentiation in mesenchymal tumors with DICER1 alteration. Our results will facilitate future investigations into prognostication and therapeutic approaches for affected patients.

Identifiants

pubmed: 36966138
doi: 10.1038/s41467-023-37092-w
pii: 10.1038/s41467-023-37092-w
pmc: PMC10039902
doi:

Substances chimiques

Ribonuclease III EC 3.1.26.3
DICER1 protein, human EC 3.1.26.3
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1677

Subventions

Organisme : CIHR
ID : FDN-148390
Pays : Canada

Informations de copyright

© 2023. The Author(s).

Références

Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Mod Pathol. 2020 Jun;33(6):1207-1219
pubmed: 31900434
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Cancer. 2015 Jan 15;121(2):276-85
pubmed: 25209242
Epigenetics. 2017 Mar 4;12(3):187-197
pubmed: 28059592
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
N Engl J Med. 2019 May 9;380(19):1834-1842
pubmed: 31067372
Mod Pathol. 2021 Jun;34(6):1226-1228
pubmed: 32572152
Am J Surg Pathol. 2008 Feb;32(2):282-95
pubmed: 18223332
Eur Respir J. 2016 Jun;47(6):1879-82
pubmed: 27126690
Hum Genet. 2014 Nov;133(11):1443-50
pubmed: 25118636
Nature. 2001 Jan 18;409(6818):363-6
pubmed: 11201747
Methods. 2015 Jan 15;72:21-8
pubmed: 25461817
Am J Surg Pathol. 2007 Oct;31(10):1459-68
pubmed: 17895746
Pediatr Blood Cancer. 2013 Dec;60(12):2091-2
pubmed: 23868280
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
J Med Genet. 2016 Jan;53(1):43-52
pubmed: 26475046
Hum Mutat. 2011 Dec;32(12):1381-4
pubmed: 21882293
Head Neck. 2013 Dec;35(12):E369-71
pubmed: 23728841
Acta Neuropathol. 2014 Oct;128(4):583-95
pubmed: 25022261
Pediatr Nephrol. 2006 Jul;21(7):1041-4
pubmed: 16773421
Mod Pathol. 2018 Jan;31(1):169-178
pubmed: 28862265
Nature. 2019 Dec;576(7786):274-280
pubmed: 31802000
Br J Cancer. 2017 Jun 6;116(12):1621-1626
pubmed: 28524158
J Neurooncol. 2022 May;157(3):499-510
pubmed: 35384518
BMC Genomics. 2012 Nov 04;13:591
pubmed: 23442169
Am J Surg Pathol. 2022 Nov 1;46(11):1477-1489
pubmed: 35941719
Acta Neuropathol. 2018 Aug;136(2):327-337
pubmed: 29881993
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Science. 2006 Jan 13;311(5758):195-8
pubmed: 16410517
Pediatr Blood Cancer. 2020 Dec;67(12):e28488
pubmed: 32568472
Science. 2009 Aug 21;325(5943):965
pubmed: 19556464
Mod Pathol. 2022 Jan;35(1):4-22
pubmed: 34599283
Br J Cancer. 2013 Nov 12;109(10):2744-50
pubmed: 24136150
Am J Surg Pathol. 2017 Sep;41(9):1178-1187
pubmed: 28654427
Nat Commun. 2021 Jan 21;12(1):498
pubmed: 33479225
Endocr Relat Cancer. 2016 Feb;23(2):L1-5
pubmed: 26545620
Pediatr Blood Cancer. 2016 Jul;63(7):1272-5
pubmed: 26928971
Am J Surg Pathol. 2019 May;43(5):628-638
pubmed: 30986800
Histopathology. 2020 Aug;77(2):223-230
pubmed: 32333409
Eur J Med Genet. 2014 Nov-Dec;57(11-12):621-5
pubmed: 25451712
JAMA. 2011 Jan 5;305(1):68-77
pubmed: 21205968
Am J Surg Pathol. 2020 Jun;44(6):738-747
pubmed: 31990691
Cancer. 2022 Feb 15;128(4):697-707
pubmed: 34674226
Mod Pathol. 2021 Dec;34(12):2096-2097
pubmed: 34642426
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Genes Chromosomes Cancer. 2021 Mar;60(3):217-233
pubmed: 33135284
Hum Pathol. 2015 Jun;46(6):917-22
pubmed: 25836323
Int J Gynecol Pathol. 2021 Sep 1;40(5):435-440
pubmed: 33021556
Nat Genet. 2017 Oct;49(10):1487-1494
pubmed: 28825729
Oncogene. 2014 Jul 24;33(30):4003-15
pubmed: 24096488
Mod Pathol. 2020 Jan;33(1):164-174
pubmed: 31537896
Science. 2003 Apr 18;300(5618):455
pubmed: 12702868
Hum Mutat. 2019 Nov;40(11):1939-1953
pubmed: 31342592
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Ann Diagn Pathol. 2022 Oct;60:152002
pubmed: 35779311
Mod Pathol. 2023 Mar;36(3):100044
pubmed: 36788095
Eur J Endocrinol. 2018 Feb;178(2):K11-K19
pubmed: 29187512
N Engl J Med. 2012 Jan 19;366(3):234-42
pubmed: 22187960
Eur J Pediatr. 2016 Apr;175(4):593-7
pubmed: 26526666
Genome Res. 2001 May;11(5):863-74
pubmed: 11337480
Clin Cancer Res. 2005 Aug 15;11(16):5740-7
pubmed: 16115911
Hum Pathol. 2016 Jul;53:114-20
pubmed: 27036314
J Clin Endocrinol Metab. 2016 Oct;101(10):3637-3645
pubmed: 27459524
Mod Pathol. 2014 Sep;27(9):1267-80
pubmed: 24481001
J Pathol Clin Res. 2022 May;8(3):294-304
pubmed: 35297207
Acta Neuropathol. 2020 Feb;139(2):243-257
pubmed: 31768671
Oncogene. 2008 Jan 10;27(3):358-65
pubmed: 17653095
Nat Rev Cancer. 2014 Oct;14(10):662-72
pubmed: 25176334
J Pathol. 2013 Jun;230(2):154-64
pubmed: 23620094
Mod Pathol. 2021 Aug;34(8):1558-1569
pubmed: 33846547
Virchows Arch. 2021 Aug;479(2):431-433
pubmed: 33825038
Acta Neuropathol. 2020 Apr;139(4):689-701
pubmed: 30953130
Oncogene. 2002 Sep 26;21(43):6694-702
pubmed: 12242669
Cancer Res. 2006 Sep 1;66(17):8462-9468
pubmed: 16951157
Bioinformatics. 2017 Dec 15;33(24):3982-3984
pubmed: 28961746
Acta Neuropathol. 2016 Jun;131(6):903-10
pubmed: 26671409
J Clin Endocrinol Metab. 2014 Jun;99(6):E1072-7
pubmed: 24617712

Auteurs

Felix K F Kommoss (FKF)

Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

Anne-Sophie Chong (AS)

Department of Human Genetics, McGill University, Montreal, QC, Canada.
Cancer Axis, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Avinguda de la Granvia de L'Hospitalet, Barcelona, Spain.

Anne-Laure Chong (AL)

Department of Human Genetics, McGill University, Montreal, QC, Canada.
Cancer Axis, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

Elke Pfaff (E)

Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.

David T W Jones (DTW)

Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Laura S Hiemcke-Jiwa (LS)

Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Lennart A Kester (LA)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Uta Flucke (U)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.

Manfred Gessler (M)

Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, Würzburg University & Comprehensive Cancer Center Mainfranken, Würzburg, Germany.

Daniel Schrimpf (D)

Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Felix Sahm (F)

Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Blaise A Clarke (BA)

Department of Pathology, University Health Network, Toronto, ON, Canada.

Colin J R Stewart (CJR)

Department of Anatomical Pathology, King Edward Memorial Hospital, Subiaco, WA, Australia.
School for Women's and Infants' Health, University of Western Australia, Perth, WA, Australia.

Yemin Wang (Y)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada.

C Blake Gilks (CB)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

Friedrich Kommoss (F)

Institute of Pathology, Medizin Campus Bodensee, Friedrichshafen, Germany.

David G Huntsman (DG)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Molecular Oncology, British Columbia Cancer Research Institute, Vancouver, BC, Canada.

Ulrich Schüller (U)

Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.

Christian Koelsche (C)

Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.

W Glenn McCluggage (WG)

Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.

Andreas von Deimling (A)

Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

William D Foulkes (WD)

Department of Human Genetics, McGill University, Montreal, QC, Canada. william.foulkes@mcgill.ca.
Cancer Axis, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada. william.foulkes@mcgill.ca.
Cancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. william.foulkes@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH